Code | 4879D | ||||||||||
MA number | EU/1/20/1436/006 | ||||||||||
Product Form: | sol inj 12x1 ml/50 mg (striek.inj.napl.skl. v pere) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Biosimilar Collaborations Ireland Limited, Ireland | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Subcutaneous use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(4) similar biological application |
MA issued: | 20.05.2020 |
Validity: | 20.05.2025 |
SmPC + PL: |
|
Safety feature | Yes |
Data update: | 08.09.2023 |